TP53 and acute myeloid leukemia: The addition of NSC59984 restored TP53 function, which was evident from increased p21 levels, which subsequently resulted in a significant increase in venetoclax-mediated apoptosis as well as downregulation of DRP1 in TP53mut AML cells.